Metoprolol succinate er half life
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Succinate ER Half-Life: Insights from Recent Research
Introduction to Metoprolol Succinate ER
Metoprolol succinate is a beta1-selective adrenergic receptor blocker commonly used to treat hypertension, angina, and arrhythmias. The extended-release (ER) formulation of metoprolol succinate is designed to provide a controlled release of the drug over an extended period, improving patient compliance and maintaining stable plasma concentrations.
Half-Life of Metoprolol Succinate ER
Pharmacokinetic Properties
The half-life of metoprolol succinate ER varies slightly depending on the formulation and the study. Generally, the half-life is reported to be between 3 to 7 hours. This range is supported by multiple studies, which indicate that the drug is rapidly absorbed in the gastrointestinal tract and requires multiple daily administrations if not formulated as an extended-release tablet Salve2021Sharma2014Kachave2021.
Sustained Release Formulations
Sustained release formulations of metoprolol succinate are designed to extend the drug's half-life and provide a more consistent therapeutic effect. For instance, one study formulated metoprolol succinate sustained release tablets using polymers, achieving a half-life of approximately 4-6 hours . Another study on controlled release osmotic tablets reported a half-life of around 3-7 hours, emphasizing the need for extended-release formulations to reduce dosing frequency and improve patient compliance .
Controlled Release Mechanisms
The controlled release mechanism of metoprolol succinate ER is achieved through various formulation techniques. For example, the metoprolol CR/Zok formulation uses individual drug delivery units (microcapsules) that deliver the drug at a near-constant rate for about 20 hours, maintaining an even plasma concentration over 24 hours with once-daily dosing . This approach minimizes plasma fluctuations and ensures consistent beta1-blockade throughout the day.
Conclusion
The half-life of metoprolol succinate ER typically ranges from 3 to 7 hours, with sustained release formulations extending the drug's therapeutic effect and improving patient compliance. These formulations are designed to provide a controlled release of the drug, maintaining stable plasma concentrations and reducing the need for multiple daily doses. The development of such formulations is crucial for the effective management of hypertension and other cardiovascular conditions.
Sources and full results
Most relevant research papers on this topic